A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Chemical Communications

• Publication date

  2017-02-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c6cc06951gPMID 28091672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-targeting peptides from combinatorial libraries.

  2017cited by this paper
• New Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-translationally Modified Peptide Natural Products.

  2016cited by this paper
• The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates

  2016cited by this paper
• Development of novel ligands for peptide GPCRs.

  2016cited by this paper
• Expanding the amino acid repertoire of ribosomal polypeptide synthesis via the artificial division of codon boxes.

  2016cited by this paper
• The evolution of genome mining in microbes - a review.

  2016cited by this paper
• A structural model for multimodular NRPS assembly lines.

  2016cited by this paper
• Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.

  2015cited by this paper
• Synthesis of fused tricyclic peptides using a reprogrammed translation system and chemical modification.

  2015cited by this paper
• A Fluorescent Imaging Probe Based on a Macrocyclic Scaffold That Binds to Cellular EpCAM

  2015cited by this paper
• Targeting protein−protein interfaces using macrocyclic peptides

  2015cited by this paper
• Artificial human Met agonists based on macrocycle scaffolds

  2015cited by this paper
• Ribosomal synthesis of an amphotericin-B inspired macrocycle.

  2014cited by this paper
• Selection-based discovery of druglike macrocyclic peptides.

  2014cited by this paper
• Reevaluation of the D-amino acid compatibility with the elongation event in translation.

  2013cited by this paper
• Nonstandard peptide expression under the genetic code consisting of reprogrammed dual sense codons.

  2013cited by this paper
• A Macrocyclic Peptide that Serves as a Cocrystallization Ligand and Inhibits the Function of a MATE Family Transporter

  2013cited by this paper
• The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.

  2013cited by this paper
• Structural basis for the drug extrusion mechanism by a MATE multidrug transporter

  2013cited by this paper
• In vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors.

  2012cited by this paper
• Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2.

  2012cited by this paper
• Selective thioether macrocyclization of peptides having the N-terminal 2-chloroacetyl group and competing two or three cysteine residues in translation.

  2012cited by this paper
• Apolar surface area determines the efficiency of translocon-mediated membrane-protein integration into the endoplasmic reticulum

  2011cited by this paper
• Flexizymes for genetic code reprogramming

  2011cited by this paper
• Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library.

  2011cited by this paper
• Ribosomal Synthesis of Backbone‐Macrocyclic Peptides Containing γ‐Amino Acids

  2011cited by this paper
• Ribosomal Synthesis of Peptides with C‐Terminal Lactams, Thiolactones, and Alkylamides

  2009cited by this paper
• Translation initiation with initiator tRNA charged with exotic peptides.

  2009cited by this paper
• Ribosomal Synthesis of Cyclic Peptides with a Fluorogenic Oxidative Coupling Reaction

  2009cited by this paper
• A flexizyme that selectively charges amino acids activated by a water-friendly leaving group.

  2009cited by this paper
• Phage-encoded combinatorial chemical libraries based on bicyclic peptides.

  2009cited by this paper
• Diverse backbone-cyclized peptides via codon reprogramming.

  2009cited by this paper
• Ribosomal synthesis of dehydrobutyrine- and methyllanthionine-containing peptides.

  2009cited by this paper
• Initiating translation with D-amino acids.

  2008cited by this paper
• Ribosomal synthesis of bicyclic peptides via two orthogonal inter-side-chain reactions.

  2008cited by this paper
• Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme

  2008cited by this paper
• Ribosomal synthesis of peptidase-resistant peptides closed by a nonreducible inter-side-chain bond.

  2008cited by this paper
• Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides.

  2008cited by this paper
• The exploration of macrocycles for drug discovery — an underexploited structural class

  2008cited by this paper
• Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides.

  2008cited by this paper
• Polymerization of α‐Hydroxy Acids by Ribosomes

  2008cited by this paper
• Ribosomal synthesis of polypeptoids and peptoid-peptide hybrids.

  2008cited by this paper
• An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides

  2007cited by this paper
• Synthesis of polyester by means of genetic code reprogramming.

  2007cited by this paper
• Enzymatic aminoacylation of tRNA with unnatural amino acids.

  2006cited by this paper
• A highly flexible tRNA acylation method for non-natural polypeptide synthesis

  2006cited by this paper
• Translation initiation by using various N-acylaminoacyl tRNAs.

  2006cited by this paper
• The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

  2003cited by this paper
• A versatile tRNA aminoacylation catalyst based on RNA.

  2003cited by this paper
• Using a solid-phase ribozyme aminoacylation system to reprogram the genetic code.

  2003cited by this paper
• Programming peptidomimetic syntheses by translating genetic codes designed de novo

  2003cited by this paper
• An Expanded Eukaryotic Genetic Code

  2003cited by this paper
• The druggable genome

  2002cited by this paper
• Outersphere and innersphere coordinated metal ions in an aminoacyl-tRNA synthetase ribozyme.

  2002cited by this paper
• Concurrent molecular recognition of the amino acid and tRNA by a ribozyme.

  2001cited by this paper
• A ribozyme exclusively aminoacylates the 3'-hydroxyl group of the tRNA terminal adenosine.

  2001cited by this paper
• An in vitro evolved precursor tRNA with aminoacylation activity

  2001cited by this paper
• Cell-free translation reconstituted with purified components

  2001cited by this paper
• In vitro virus: Bonding of mRNA bearing puromycin at the 3′‐terminal end to the C‐terminal end of its encoded protein on the ribosome in vitro

  1997cited by this paper
• RNA-peptide fusions for the in vitro selection of peptides and proteins.

  1997cited by this paper
• The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

  1994cited by this paper
• A general method for site-specific incorporation of unnatural amino acids into proteins.

  1989cited by this paper

• The effect of peptide size on target affinity in mRNA display-derived macrocyclic peptides.

  2026cites this paper
• From Serendipity to Strategy: Rationalizing Molecular Glue Discovery and Proximity-Induced Pharmacology through Chemical Biology

  2026cites this paper
• A General Synthesis Approach to Double‐Guanidinium Stapled Peptides and Foldamers

  2025cites this paper
• Macrocyclic Compounds: Unveiling Their Distinctive Antiviral Advantages in Medicinal Research.

  2025cites this paper
• Using extension‐based mRNA display to design antibody‐like proteinogenic peptides for human PD‐L1

  2025cites this paper
• Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4.

  2025cites this paper
• Shaping the future of constrained peptides and compact proteins in drug discovery

  2025cites this paper
• De Novo Discovery of Bicyclic Competitive Inhibitors of Zika Virus Protease from Peptide–Bismuth Phage Display Screening

  2025cites this paper
• De novo cyclic peptides allow visualisation of the monomeric and functional amyloid conformations of the kinase RIPK3

  2025influential citation
• Cyclic peptides as ligands for competition binding assays.

  2025cites this paper
• Ribosomal Synthesis of Topologically Defined Thioisoindole‐Bridged Bicyclic Peptides

  2025cites this paper
• Small molecule antipathogenic agents against Staphylococcus aureus infections.

  2025cites this paper
• Diversity Scale of Library Matters: Impact of mRNA Library Diversity Scales on the Discovery of Macrocyclic Peptides Targeting a Protein by the RaPID System

  2025cites this paper
• Expanded ribosomal synthesis of non-standard cyclic backbones in vitro

  2025cites this paper
• Active- and Allosteric-Site Cyclic Peptide Inhibitors of Secreted M. tuberculosis Chorismate Mutase.

  2025cites this paper
• From De Novo to Xeno: Advancing Macromolecule Design beyond Proteins.

  2024cites this paper
• Cell-Free Gene Expression: Methods and Applications

  2024cites this paper
• Discovery of Selective Cyclic d-Sulfopeptide Ligands of the Chemokine CCL22 via Mirror-Image mRNA Display with Genetic Reprogramming.

  2024cites this paper
• De Novo Discovery of a Noncovalent Cell-Penetrating Bicyclic Peptide Inhibitor Targeting SARS-CoV-2 Main Protease.

  2024cites this paper
• Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets

  2024cites this paper
• Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9

  2024cites this paper
• Mirror‐Image Random Nonstandard Peptides Integrated Discovery (MI‐RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7

  2024cites this paper
• Oxidation-guided and collision-induced linearization assists de novo sequencing of thioether macrocyclic peptides.

  2024cites this paper
• A cyclic peptide-grafted Fc with hepatocyte growth factor functionality ameliorates hepatic fibrosis in a non-alcoholic steatohepatitis mouse model

  2024cites this paper
• Accessing diverse bicyclic peptide conformations using 1,2,3-TBMB as a linker.

  2024cites this paper
• Expression and Subcellular Localization of Lanthipeptides in Human Cells

  2024cites this paper
• Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy

  2024cites this paper
• Engineering tRNAs for the Ribosomal Translation of Non-proteinogenic Monomers

  2024cites this paper
• mRNA display in cell lysates enables identification of cyclic peptides targeting the BRD3 extraterminal domain

  2024cites this paper
• The coming of age of cyclic peptide drugs: an update on discovery technologies

  2024cites this paper
• Biocompatible strategies for peptide macrocyclisation

  2024cites this paper
• Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches

  2024cites this paper
• Identification of specific carbonic anhydrase inhibitors via in situ click chemistry, phage-display and synthetic peptide libraries: comparison of the methods and structural study.

  2023cites this paper
• Selective modification of tryptophan in polypeptides via C-N coupling with azoles using in situ-generated iodine-based oxidants in aqueous media.

  2023cites this paper
• Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity.

  2023cites this paper
• AAp-MSMD: Amino Acid Preference Mapping on Protein–Protein Interaction Surfaces Using Mixed-Solvent Molecular Dynamics

  2023cites this paper
• Cyclic Peptide Linker Design and Optimization by Molecular Dynamics Simulations

  2023cites this paper
• Expression of Lanthipeptides in Human Cells

  2023cites this paper
• Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets.

  2023cites this paper
• Harnessing Aromatic-Histidine Interactions through Synergistic Backbone Extension and Side Chain Modification.

  2023cites this paper
• Advances in Ultrahigh Throughput Hit Discovery with Tandem Mass Spectrometry Encoded Libraries

  2023cites this paper
• Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS

  2023cites this paper
• mRNA display reveals a class of high-affinity bromodomain-binding motifs that are not found in the human proteome

  2023cites this paper
• Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function

  2023cites this paper
• Chemically modified antiviral peptides against SARS‐CoV‐2

  2023cites this paper
• Inhibitors targeting BamA in gram-negative bacteria.

  2023cites this paper
• Phage display uncovers a sequence motif that drives polypeptide binding to a conserved regulatory exosite of O-GlcNAc transferase

  2023cites this paper
• Cell-free Biosynthesis of Peptidomimetics

  2023cites this paper
• Discovery and characterization of cyclic peptides selective for the C-terminal bromodomains of BET family proteins

  2022cites this paper
• Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation system

  2022cites this paper
• A Cyclisation and Docking Protocol for Cyclic Peptide-Protein Modelling using HADDOCK2.4

  2022cites this paper
• Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography

  2022cites this paper
• Antiviral cyclic peptides targeting the main protease of SARS-CoV-2

  2022cites this paper
• Cyclization and Docking Protocol for Cyclic Peptide–Protein Modeling Using HADDOCK2.4

  2022cites this paper
• Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2

  2022cites this paper
• Serum-Stable and Selective Backbone-N-Methylated Cyclic Peptides That Inhibit Prokaryotic Glycolytic Mutases.

  2022cites this paper
• Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region

  2022cites this paper
• Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening

  2022cites this paper
• Cell-Free PURE System: Evolution and Achievements

  2022cites this paper
• Programmable Synthesis of Biobased Materials Using Cell‐Free Systems

  2022cites this paper
• Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate

  2022cites this paper
• Incorporation of Non-Canonical Amino Acids into Antimicrobial Peptides: Advances, Challenges, and Perspectives

  2022cites this paper
• DNA-Encoded Libraries: Towards Harnessing their Full Power with Darwinian Evolution.

  2022cites this paper
• Potent De Novo Macrocyclic Peptides that Inhibit O-GlcNAc Transferase Through an Allosteric Mechanism.

  2022cites this paper
• An amber-encoding helper phage for more efficient phage display of noncanonical amino acids

  2022cites this paper
• The Discovery of Peptide Macrocycle Rescuers of Pathogenic Protein Misfolding and Aggregation by Integrating SICLOPPS Technology and Ultrahigh-Throughput Screening in Bacteria.

  2022cites this paper
• Converting peptides into drugs targeting intracellular protein-protein interactions.

  2021cites this paper
• Trends in peptide drug discovery

  2021cites this paper
• A DNA-encoded chemical library based on peptide macrocycles.

  2021cites this paper
• Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure.

  2021cites this paper
• Engineering of a Peptide α‐N‐Methyltransferase to Methylate Non‐Proteinogenic Amino Acids

  2021cites this paper
• De novo macrocyclic peptides dissect energy coupling of a heterodimeric ABC transporter by multimode allosteric inhibition

  2021cites this paper
• Target-templated de novo design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1†

  2021cites this paper
• Biosynthetic Strategies for Macrocyclic Peptides

  2021cites this paper
• Cyclisation strategies for stabilising peptides with irregular conformations.

  2021cites this paper
• Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors

  2021cites this paper
• Discovery of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2 via mRNA Display

  2021cites this paper
• Agonist/Antagonist Activity of Oxytocin Variants Obtained from Free Cyclic Peptide Libraries Generated via Amino Acid Substitution

  2021cites this paper
• Compound Screening

  2021cites this paper
• Extended Solution-phase Peptide Synthesis Strategy Using Isostearyl-Mixed Anhydride Coupling and a New C-Terminal Silyl Ester-Protecting Group for N-Methylated Cyclic Peptide Production

  2021cites this paper
• Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy.

  2021cites this paper
• De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist

  2021cites this paper
• An Ultrapotent and Selective Cyclic Peptide Inhibitor of Human β-Factor XIIa in a Cyclotide Scaffold.

  2021cites this paper
• Macrocyclic Peptide-Conjugated Tip for Fast and Selective Molecular Recognition Imaging by High-Speed Atomic Force Microscopy.

  2021cites this paper
• Cyclic peptide drugs approved in the last two decades (2001–2021)

  2021cites this paper
• Engineering of a Peptide α‐N‐Methyltransferase to Methylate Non‐Proteinogenic Amino Acids

  2021cites this paper
• Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT)

  2020cites this paper
• Hijacking Translation Initiation for Synthetic Biology

  2020cites this paper
• Nongenetic engineering strategies for regulating receptor oligomerization in living cells.

  2020cites this paper
• The Thioredoxin System: a Promising Target for Cancer Drug Development.

  2020cites this paper
• Affinity Maturation of Macrocyclic Peptide Modulators of Lys48-linked Diubiquitin by a Twofold Strategy.

  2020cites this paper
• Discovery of Potent Cyclic Sulfopeptide Chemokine Inhibitors via Reprogrammed Genetic Code mRNA Display.

  2020cites this paper
• Macrocyclic peptides that inhibit Wnt signalling via interaction with Wnt3a

  2020cites this paper
• Recent Advances in Engineering Ribosomes for Natural Product Biosynthesis

  2020cites this paper
• Poly(alanine-nylon-alanine) as a bioplastic: chemoenzymatic synthesis, thermal properties and biological degradation effects

  2020cites this paper
• Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis

  2020cites this paper
• Improving membrane permeation in the beyond rule-of-five space by using prodrugs to mask hydrogen bond donors.

  2020cites this paper
• A macrocyclic peptide library with a structurally constrained cyclopropane-containing building block leads to thiol-independent inhibitors of phosphoglycerate mutase.

  2020cites this paper
• Peptide and Protein Engineering: From Concepts to Biotechnological Applications

  2020cites this paper
• Noncanonical Amino Acids in Synthetic Biosafety and Post‐translational Modification Studies

  2020cites this paper